About DNARx

DNARx is a company creating gene-based therapeutics. It utilizes a proprietary, nonviral, gene therapy platform, called HEDGES (high-level extended duration gene expression system), that enables durable expression, repeat dosing, and large DNA constructs that can express multiple genes simultaneously. The technology can be applied to the development of a treatment for cancer, heart disorders, Alzheimer’s, and pandemic diseases.